80
Participants
Start Date
April 30, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
December 31, 2015
Ezetimibe
Patients on standard immunosuppressive therapy with statin will be added ezetimibe for 6 months. Thereafter ezetimibe will be discontinued for three months. Biochemical parameters will be analysed at the time of enrolment, after 3 months, 6 months and 9 months.
University Medical Center Ljubljana, Ljubljana
University Medical Centre Ljubljana
OTHER